TrialGynecologic oncology2013
Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer-a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG.
Florian Heitz et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this paperpooled ittrialcites it